USPTO serial 79217175
Serial No. 79217175
Reviewed by CopyMark Law Group
Reg. 5619543Status 709
- Filing date
- Status date
- Registration date
- Dec 4, 2018
- Examiner
- GULIANO, ROBERT N
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with Serial No. 79217175?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow Smith, Gambrell, Russell, LLP1055 Thomas Jefferson St. NW, Suite 400Washington, DC 20007UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry, science, photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins, unprocessed plastics; soil fertilizers; fire-extinguishing compositions; tempering preparations and soldering chemicals; chemical substances for preserving foodstuffs; tanning agents for use in manufacturing leather; adhesives for use in industry | SECTION 71 - CANCELLED | — |
| 003 | Bleaching preparations for laundry use; cleaning, polishing, degreasing and abrasive preparations for household purposes | SECTION 71 - CANCELLED | — |
| 005 | Pharmaceutical, veterinary and sanitary products, namely, pharmaceutical anti-allergic preparations and substances; pharmaceutical for the treatment of erectile dysfunction; pharmaceutical preparations, namely, anticoagulants; pharmaceutical preparations, namely, antidepressants; pharmaceutical preparations, namely, appetite suppressants; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparation for the treatment of gout; pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of stem cell mobilization; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; pharmaceutical preparations for animal skincare; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for ocular or intraocular surgery; pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; pharmaceutical preparations for treating allergic rhinitis and asthma; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for wounds; pharmaceutical preparations for use in urology; pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical products and preparations for chloasma; pharmaceutical products and preparations for hydrating the skin during pregnancy; pharmaceutical products and preparations for pregnancy blemishes; pharmaceutical products and preparations for preventing skin blemishes during pregnancy; pharmaceutical products and preparations to prevent stretch marks; pharmaceutical products and preparations to prevent swelling in the legs; pharmaceutical products for ophthalmological use; pharmaceutical products for the treatment of bone diseases; pharmaceutical products for the treatment of viral and infectious diseases and for the treatment of cancer; pharmaceutical products for treating respiratory diseases and asthma; pharmaceutical skin lotions; pharmaceutical solutions used in dialysis; pharmaceuticals, namely, antihelmitics; pharmaceuticals, namely, inducers of erections; pharmaceuticals, namely, lipid lowering agents; pharmaceuticals, namely, psychotropics; pharmaceuticals, namely, anti-infectives; veterinary preparations, namely, pain relief medication; veterinary preparations for the treatment of intestinal bacteria; veterinary vaccine for horses, veterinary vaccines; sanitary preparations for medical purposes; dietetic foods and beverages adapted for medical use; food for babies; medical plasters, medical dressings; material for dental fillings and dental impressions; disinfectants; preparations for destroying vermin; fungicides, herbicides | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services namely research and design services in the field of agrochemicals, pharmaceuticals and bio-chemistry; analysis of industrial fluids; design and development of computers and software | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Polyphor AG
- Other trademarks owned by Polyphor AG
- Other trademarks owned by Polyphor AG
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 042
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 20, 2026 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 20, 2025 | C71T | CANCELLED SECTION 71 | — |
| Dec 4, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Oct 29, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 7, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 5, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 18, 2019 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 18, 2019 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Mar 4, 2019 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Dec 4, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 18, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 18, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 15, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 29, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 29, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Aug 29, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 13, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 19, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 23, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 21, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jun 7, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 9, 2018 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2018 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 30, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 30, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jan 8, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 8, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 8, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 17, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 28, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 28, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 24, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 23, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 6, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 2, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 28, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |